Evidence map›Paper›PMID 34375701›Full record

ArticleAmerican journal of infection control2021

Absence of SARS-CoV-2 infections among patients with end-stage renal disease following facility-wide testing in four outpatient hemodialysis facilities.

W Wyatt Wilson, Ana C Bardossy, Paige Gable, Carolyn Herzig, Elizabeth Beshearse, Nicole Gualandi, Sarah Sabour, Nicole Brown, Allison C Brown, Preeta Kutty and 5 more

Abstract read
In one paragraph

Article in American journal of infection control, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

W Wyatt WilsonEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: wuw7@cdc.gov.
Ana C BardossyDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Paige GableDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Carolyn HerzigDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Elizabeth BeshearseEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Nicole GualandiDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Sarah SabourDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Nicole BrownDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Allison C BrownDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Preeta KuttyDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Melissa Tobin-D'AngeloAcute Disease Epidemiology Section, Georgia Department of Public Health, Atlanta, GA.
Janice P LeaDivision of Renal Medicine, Department of Medicine, Emory School of Medicine, Atlanta, GA.
Ibironke W ApataDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA; Division of Renal Medicine, Department of Medicine, Emory School of Medicine, Atlanta, GA.
Shannon NovosadDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Implementation Team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Facility-wide testing performed at 4 outpatient hemodialysis facilities in the absence of an outbreak or escalating community incidence did not identify new SARS-CoV-2 infections and illustrated key logistical considerations essential to successful implementation of SARS-CoV-2 screening. Facilities could consider prioritizing facility-wide SARS-CoV-2 testing during suspicion of an outbreak in the facility or escalating community spread without robust infection control strategies in place. Being prepared to address operational considerations will enhance implementation of facility-wide testing in the outpatient dialysis setting.

Indexed as

COVID-19Kidney Failure, ChronicCOVID-19 TestingHumansOutpatientsRenal DialysisSARS-CoV-2COVID-19End-Stage Renal DiseaseFacility-wide testing SARS-CoV-2Hemodialysis

Identifiers

PMID34375701
PMCPMC8349431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.